DIA
AMGN icon

Dean Investment Associates’s Amgen AMGN Stock Holding History

Dean Investment Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.26M Sell
23,485
-1,259
-5% -$449K 1.16% 9
2025
Q4 		$8.1M Buy
24,744
+4,182
+20% +$1.33M 1.16% 10
2025
Q3 		$5.8M Buy
20,562
+2,742
+15% +$795K 0.81% 22
2025
Q2 		$4.98M Buy
17,820
+4,209
+31% +$1.19M 0.73% 37
2025
Q1 		$4.24M Sell
13,611
-1,309
-9% -$387K 0.63% 46
2024
Q4 		$3.89M Sell
14,920
-346
-2% -$103K 0.55% 58
2024
Q3 		$4.92M Sell
15,266
-449
-3% -$147K 0.67% 42
2024
Q2 		$4.91M Sell
15,715
-1,455
-8% -$427K 0.7% 46
2024
Q1 		$4.88M Sell
17,170
-6,864
-29% -$2.01M 0.67% 48
2023
Q4 		$6.92M Sell
24,034
-7,359
-23% -$2.01M 0.99% 13
2023
Q3 		$8.44M Sell
31,393
-151
-0.5% -$37.7K 1.38% 6
2023
Q2 		$7M Buy
31,544
+36
+0.1% +$8.35K 1.14% 15
2023
Q1 		$7.62M Buy
31,508
+5,038
+19% +$1.24M 1.22% 13
2022
Q4 		$6.95M Buy
26,470
+2,195
+9% +$588K 1.18% 7
2022
Q3 		$5.47M Buy
24,275
+11,384
+88% +$2.76M 1.12% 9
2022
Q2 		$3.14M Sell
12,891
-30
-0.2% -$7.35K 0.61% 54
2022
Q1 		$3.13M Buy
12,921
+325
+3% +$74.7K 0.56% 65
2021
Q4 		$2.83M Sell
12,596
-343
-3% -$72.4K 0.5% 75
2021
Q3 		$2.75M Buy
12,939
+228
+2% +$52.5K 0.52% 71
2021
Q2 		$3.1M Buy
12,711
+126
+1% +$31K 0.57% 58
2021
Q1 		$3.13M Hold
12,585
– – 0.59% 51
2020
Q4 		$2.89M Sell
12,585
-507
-4% -$117K 0.6% 53
2020
Q3 		$3.33M Sell
13,092
-174
-1% -$43.1K 0.8% 26
2020
Q2 		$3.13M Sell
13,266
-4,216
-24% -$962K 0.75% 36
2020
Q1 		$3.54M Sell
17,482
-628
-3% -$137K 0.76% 30
2019
Q4 		$4.37M Sell
18,110
-245
-1% -$54K 0.68% 47
2019
Q3 		$3.55M Buy
18,355
+715
+4% +$137K 0.52% 84
2019
Q2 		$3.25M Buy
17,640
+370
+2% +$66.3K 0.47% 103
2019
Q1 		$3.28M Buy
17,270
+401
+2% +$76.6K 0.48% 97
2018
Q4 		$3.28M Buy
16,869
+1,663
+11% +$324K 0.52% 90
2018
Q3 		$3.15M Buy
15,206
+1,505
+11% +$297K 0.44% 107
2018
Q2 		$2.53M Sell
13,701
-276
-2% -$48.8K 0.37% 115
2018
Q1 		$2.38M Buy
13,977
+2,388
+21% +$438K 0.35% 112
2017
Q4 		$2.02M Buy
11,589
+334
+3% +$59.1K 0.31% 133
2017
Q3 		$2.1M Buy
11,255
+139
+1% +$24.6K 0.32% 123
2017
Q2 		$1.92M Buy
11,116
+1,015
+10% +$165K 0.29% 122
2017
Q1 		$1.66M Buy
10,101
+964
+11% +$160K 0.28% 115
2016
Q4 		$1.34M Buy
+9,137
New +$1.38M 0.23% 119

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dean Investment Associates's AMGN Position: Q1 2026 in Review

Dean Investment Associates reduced its Amgen (AMGN) stake by 5.1% in Q1 2026, selling an estimated $449K and leaving 23,485 shares worth $8.26M. The position accounts for 1.16% of the portfolio, ranked #9.

Dean Investment Associates first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $8.44M in Q3 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Dean Investment Associates held 23,485 shares of Amgen worth $8.26M as of Q1 2026.
  • Dean Investment Associates sold 1,259 Amgen shares in Q1 2026, an estimated $449K.
  • Amgen made up 1.16% of Dean Investment Associates's portfolio in Q1 2026, its #9 holding.
  • Dean Investment Associates first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
  • Dean Investment Associates's Amgen position peaked at $8.44M in Q3 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.